İ Gulcin, OV Petrova, P Taslimi, SF Malysheva… - …, 2022 - Wiley Online Library
In this study, a series of nitrogen‐based novel heterocyclic compounds were synthesized and characterized by elemental analysis, IR and NMR spectra. The novel synthesized …
N Cichon, W Grabowska, L Gorniak, M Stela… - Nutrients, 2024 - mdpi.com
Flavonoids are naturally occurring polyphenolic compounds known for their extensive range of biological activities. This review focuses on the inhibitory effects of flavonoids on …
Alzheimer's disease (AD) is one of the most common forms of dementia and is associated with a decline in cognitive function and language ability. The deficiency of the cholinergic …
Z Zhang, J Lv, Y Wang, H Yu, B Guo… - … A European Journal, 2023 - Wiley Online Library
Acetylcholinesterase (AChE) is a key target for the current symptomatic treatment of Alzheimer's disease, and galantamine is a clinical anticholinesterase drug with transiently …
JH Liang, HR Lin, CS Yang, CC Liaw, IC Wang… - Antioxidants, 2022 - mdpi.com
The dried root of Ampelopsis japonica (Thunb.) Makino (A. japonica.) is a traditional medicine used to treat fever, pain, and wound healing. It exhibits anti-inflammatory …
Abstract Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are enzymes that belong to the neuromuscular cholinergic system, their main function is to hydrolyze the …
In addition to the first synthesis of the natural bromophenol butyl 2‐(3, 5‐dibromo‐4‐ hydroxyphenyl) acetate (1), indene derivatives 34 and 35 were synthesized from 3 …
AL Turcu, J Companys-Alemany, MB Phillips… - European journal of …, 2022 - Elsevier
Currently, of the few accessible symptomatic therapies for Alzheimer's disease (AD), memantine is the only N-methyl-d-aspartate receptor (NMDAR) blocker approved by the …
Acetylcholinesterase (AChE) and beta-secretase (BACE-1) are the two crucial enzymes involved in the pathology of Alzheimer's disease. The former is responsible for many defects …